When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Hiperparatiroidismo primario

Last reviewed: 22 Aug 2025
Last updated: 08 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • hallazgo incidental en las pruebas bioquímicas
  • antecedentes de osteoporosis u osteopenia
  • antecedentes familiares de hiperparatiroidismo o características que indican hipercalcemia
  • nefrolitiasis
Full details

Other diagnostic factors

  • trastornos del sueño
  • fatiga
  • mialgia
  • ansiedad
  • depresión
  • pérdida de la memoria
  • disfunción neuromuscular evidente
  • disfunción cardiovascular y metabólica
  • síntomas gastrointestinales
Full details

Risk factors

  • sexo femenino
  • ≥50-60 años de edad
  • neoplasia endocrina múltiple (MEN) 1, 2A o 4
  • tratamiento con litio previo o actual
  • síndrome de hiperparatiroidismo por tumor maxilar
  • antecedentes familiares de HPTP
  • antecedentes de irradiación de cabeza o cuello.
Full details

Diagnostic investigations

1st investigations to order

  • calcio sérico
  • PTH intacta sérica con ensayo inmunoquímico o inmunoradiométrico
Full details

Investigations to consider

  • nivel de 25-hidroxivitamina D
  • fosfatasa alcalina en suero
  • fósforo sérico
  • calciuria de 24 horas
  • exploración por radioabsorciometría de doble energía (DEXA)
  • puntaje óseo trabecular
  • ecografía de cuello
  • exploración con tecnecio-99m sestamibi
  • TC de emisión monofotónica (SPECT)
  • TC de cuello
  • TC cuatridimensional (4D) del cuello
  • IRM de cuello
Full details

Emerging tests

  • colina radiomarcada PET
  • aprendizaje automático para identificar el hiperparatiroidismo primario

Treatment algorithm

ONGOING

asintomático sin indicaciones quirúrgicas o sintomático

asintomático sin indicaciones quirúrgicas

Contributors

Authors

John Ayuk, MD

Consultant Endocrinologist

University Hospitals Birmingham

Birmingham

UK

Disclosures

JA declares that he has no competing interests.

Neil Gittoes, MD, PhD

Consultant Endocrinologist and Honorary Professor of Endocrinology

Associate Medical Director

University Hospitals Birmingham

Birmingham

UK

Disclosures

NG is an author of several references cited in this topic and is a member of the 2021 European Society of Endocrinology Educational Program of Parathyroid Disorders (PARAT) Working Group.

Acknowledgements

Dr John Ayuk and Professor Neil Gittoes would like to gratefully acknowledge Dr Fausto Palazzo, Dr Swaroop Gantela, and Dr Nancy D. Perrier, the previous contributors to this topic. FP, SG, and NDP declare that they have no competing interests.

Peer reviewers

Brendan C. Stack Jr, MD, FACS, FACE

Chairman, Endocrine Surgery Section

American Head and Neck Society

Professor and former inaugural Chairman

Department of Otolaryngology-Head and Neck Surgery

Southern Illinois University School of Medicine

Springfield

IL

Disclosures

BCS declares that he has no competing interests.

Petros Perros, BSc, MBBS, MD, FRCP

Department of Endocrinology

Elliott Building

Royal Victoria Infirmary

Newcastle-upon-Tyne

UK

Disclosures

PP declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Bilezikian JP, Khan AA, Silverberg SJ, et al. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth International Workshop. J Bone Miner Res. 2022 Nov;37(11):2293-314.Full text  Abstract

Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016 Oct 1;151(10):959-68.Full text  Abstract

Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders. Eur J Endocrinol. 2022 Feb 1;186(2):R33-63.Full text  Abstract

Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.Full text  Abstract

Petranović Ovčariček P, Giovanella L, Carrió Gasset I, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2801-2822.Full text  Abstract

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Diagnósticos diferenciais

    • Hipercalcemia hipocalciúrica familiar (FHH)
    • Hipercalcemia humoral de neoplasia maligna
    • Mieloma múltiple
    Mais Diagnósticos diferenciais
  • Diretrizes

    • European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy
    • Practice parameter for the performance and interpretation of diagnostic ultrasound of the thyroid and extracranial head and neck
    Mais Diretrizes
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer